This report provides a comprehensive analysis of the monoclonal antibody (mAbs) therapeutics market, projecting its growth from an estimated USD 252.6 billion in 2024 to USD 497.5 billion by 2029...
The global monoclonal antibodies (mAbs) market is currently experiencing substantial growth and is projected to maintain a strong upward trajectory over the next decade. Valued at approximately U...
Introduction
In the rapidly advancing world of biotechnology, monoclonal antibodies (mAbs) have emerged as one of the most transformative therapeutic tools in medicine. From cancer immunotherapy t...
